[Sample Preparation and Sequencing Efficiency of microRNA Libraries from Pituitary Adenoma Tissue and Blood Plasma of Patients with Acromegaly for the Illumina Platform].

Q3 Medicine
E V Ignatieva, E S Nerubenko, O A Ivanova, U A Tsoy, R I Dmitrieva
{"title":"[Sample Preparation and Sequencing Efficiency of microRNA Libraries from Pituitary Adenoma Tissue and Blood Plasma of Patients with Acromegaly for the Illumina Platform].","authors":"E V Ignatieva, E S Nerubenko, O A Ivanova, U A Tsoy, R I Dmitrieva","doi":"10.31857/S0026898425020121, EDN: GFUSPR","DOIUrl":null,"url":null,"abstract":"<p><p>MicroRNAs in tissues and biological fluids represent a promising class of biomarkers for the molecular diagnostics and therapy of numerous diseases, including oncological diseases. Biomarkers based on easily accessible biological fluids, primarily blood-based biomarkers, are of particular value for diagnostic and prognostic purposes. To explore the potential of microRNAs as prognostic cancer markers and targets for molecular therapy, global microRNA profiling is required, which is provided by next-generation sequencing (NGS). NGS offers high sensitivity, single nucleotide resolution, and the possibility of profiling a large number of samples in parallel. Despite the promising potential of microRNAs as biomarkers and the growing number of works in this area, the literature does not address in sufficient detail the problems associated with sample preparation methods, the specifics of library preparation for microRNA sequencing, and the difficulties of quantitative analysis. Protocols for creating libraries for microRNA sequencing present specific challenges and require selecting conditions for each type of biological sample. Here, we present in detail the preparation of libraries for microRNA sequencing from pituitary adenoma tumor tissue and blood plasma of patients with acromegaly on the Illumina platform. We discuss the difficulties and limitations of the methods and evaluate the effectiveness of sequencing plasma and brain samples. This work can serve as a guide for researchers studying the mechanisms of microRNA regulation in endocrine diseases of the pituitary gland and will also allow for the adaptation of technical procedures for various biological samples in relation to other pathologies.</p>","PeriodicalId":39818,"journal":{"name":"Molekulyarnaya Biologiya","volume":"59 2","pages":"309-323"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molekulyarnaya Biologiya","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31857/S0026898425020121, EDN: GFUSPR","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

MicroRNAs in tissues and biological fluids represent a promising class of biomarkers for the molecular diagnostics and therapy of numerous diseases, including oncological diseases. Biomarkers based on easily accessible biological fluids, primarily blood-based biomarkers, are of particular value for diagnostic and prognostic purposes. To explore the potential of microRNAs as prognostic cancer markers and targets for molecular therapy, global microRNA profiling is required, which is provided by next-generation sequencing (NGS). NGS offers high sensitivity, single nucleotide resolution, and the possibility of profiling a large number of samples in parallel. Despite the promising potential of microRNAs as biomarkers and the growing number of works in this area, the literature does not address in sufficient detail the problems associated with sample preparation methods, the specifics of library preparation for microRNA sequencing, and the difficulties of quantitative analysis. Protocols for creating libraries for microRNA sequencing present specific challenges and require selecting conditions for each type of biological sample. Here, we present in detail the preparation of libraries for microRNA sequencing from pituitary adenoma tumor tissue and blood plasma of patients with acromegaly on the Illumina platform. We discuss the difficulties and limitations of the methods and evaluate the effectiveness of sequencing plasma and brain samples. This work can serve as a guide for researchers studying the mechanisms of microRNA regulation in endocrine diseases of the pituitary gland and will also allow for the adaptation of technical procedures for various biological samples in relation to other pathologies.

[用于Illumina平台的垂体腺瘤组织和肢端肥大症患者血浆microRNA文库的样品制备和测序效率]。
组织和生物体液中的microrna代表了一类有前途的生物标志物,可用于包括肿瘤疾病在内的许多疾病的分子诊断和治疗。基于易于获取的生物液体的生物标志物,主要是基于血液的生物标志物,在诊断和预后方面具有特别的价值。为了探索microRNA作为预后癌症标志物和分子治疗靶点的潜力,需要通过下一代测序(NGS)提供全球microRNA谱分析。NGS具有高灵敏度、单核苷酸分辨率和并行分析大量样品的可能性。尽管microRNA作为生物标志物具有广阔的潜力,在这一领域的工作也越来越多,但文献并没有充分详细地解决与样品制备方法相关的问题,microRNA测序文库制备的细节,以及定量分析的困难。创建microRNA测序文库的协议提出了具体的挑战,需要为每种类型的生物样品选择条件。在此,我们详细介绍了在Illumina平台上制备垂体腺瘤肿瘤组织和肢端肥大症患者血浆中用于microRNA测序的文库。我们讨论了这些方法的困难和局限性,并评估了血浆和脑样本测序的有效性。这项工作可以为研究垂体内分泌疾病中microRNA调控机制的研究人员提供指导,也将允许适应与其他病理相关的各种生物样品的技术程序。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Molekulyarnaya Biologiya
Molekulyarnaya Biologiya Medicine-Medicine (all)
CiteScore
0.70
自引率
0.00%
发文量
131
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信